Access to Information Requests Completed - May 2012

The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)

If you wish to obtain a copy of the records released in response to these requests informally, you contact the Access to Information and Privacy Division.

Completed Requests

For the month of May 2012

Request #	Summary of Requests	Status of Completed Request	Number of Pages Disclosed
A-2009-00862	All briefing notes including memos created or forwarded to the minister responsible for health. (Sep 28, 2009 to Oct 14, 2009).	Disclosed in part	325
A-2010-00440	Information regarding the product Nifedipine, DIN 02349167 by Mylan Pharmaceuticals.	Disclosed in part	223
A-2010-00564	Inspection reports issued to clinic trial sponsors in 2009 and 2010, for studies conducted at the Montreal General Hospital.	Disclosed in part	235
A-2010-01156	All documents relating to the following medical devices: Stryker Trident Acetbular Shell, Trident Hemispherical Cluster Hole Shell, and Trident Alumina Ceramic Cup Inserts. (Jan 1, 1999 to Jan 11, 2011).	Disclosed in part	1,027
A-2010-01335	All documents relating to evaluation or re-evaluation of tartrazine as a food additive and/or containing guidelines for limiting or controlling the use of tartrazine.	Disclosed in part	635
A-2010-01519	All correspondence on the topic of Antibiotics and Livestock prepared for the Minister of Health following the Canadian Broadcasting Corporation (CBC) broadcast on February 11, 2011.	All disclosed	126
A-2010-01529	All documents related to the association between of the use of MultiHance and other gadolinium-based contrast agents and nephrogenic systemic fibrosis.	Disclosed in part	763
A-2010-01586	Complete review of case reports and available literature of the risk of nephrogenic systemic fibrosis (NSF) associated with the use of various gadolinium-based contrast agents (GBCA) that was performed by Health Canada.	Disclosed in part	763
A-2011-00006	Information regarding the product Omnitrope by Sandoz.	Disclosed in part	596
A-2011-00107	All documents pertaining to project or program funding agreements with and subsequent deliverables to Health Canada by: Physicians for a Smoke-Free Canada (PSC).	Disclosed in part	5,633
A-2011-00127	All records relating to bonus payment schemes for employees of Health Canada Infoway, Inc.	Disclosed in part	31
A-2011-00130	Information regarding the product Virginiamycin Premix, DIN 02215691 by Bio Agri Mix LP.	Disclosed in part	155
A-2011-00323	All documents in MECS for the following files: 09-137849-395, 10-104108-420, 10-103177-151, 10-000701-312, 09-129881-484, 10-105767-753.	Disclosed in part	53
A-2011-00481	List of studies that were submitted during its initial registration of the technical grade active ingredient of Sencor Metribuzuin Technical (PCP20537) and of the end use product known as Sencor 75 DF Herbicide (PCP17242).	Disclosed in part	79
A-2011-00592	A copy of each tobacco ad published. (Jan 1, 2010 to Jun 30, 2011).	Disclosed in part	107
A-2011-00609	Information about tobacco companies' advertising habits for manufacturers or importers who used a sign to promote a product, specified the manner of displaying a product at retail, or paid a fee for the display of a product. (Jan 1, 2010 to Jun 30, 2011).	Disclosed in part	147
A-2011-00668	All reports of examination for Customs Entry and records of importation or attempted importation, including seizure notices for commercial imports, which identify the products as counterfeit or suspected counterfeit products. (Jan 1, 2010 to Sep 8, 2011).	Disclosed in part	824
A-2011-00788	Any risk assessment report(s) prepared by Health Canada to determine sentinel events for the medication incidents involving Pradax and the analysis of medication system and process based factors that may have contributed to those medication incidents.	Disclosed in part	73
A-2011-00802	Documentation pertaining to Non-smoker's Rights Association (NSRA)  Dated 06/21/11. Physicians for a Smoke Free Canada (PSC)  Dated 06/16/2011. Canadian Council on Tobacco Control (CCTC) Dated 05/18/2011 Info-Tabac 03/31/2011.	Disclosed in part	1,207
A-2011-00808	All documents submitted by BASF in support of the following decision approval; Product/Designation: Canola B. juncea Applicant at time of application: BASF Canada Inc. Novel Trait(s): Imidazolinone tolerance.	Disclosed in part	235
A-2011-00818	Documents and evidence submitted to support a novel food application and approval for Camelina oil (company name Canpressco, Decision date January 7, 2010).	Disclosed in part	540
A-2011-00841	All documents relating to consideration of requiring Health Canada Infoway Inc., to disclose the total annual compensation for each officer director and employee whose compensation exceeds $100,000 per year.	All excluded	0
A-2011-00915	All documents in relation to recommendations by the Expert Panel on Caffeinated Energy Drinks made in regards to energy drinks. (Oct 26, 2010 to Oct 31, 2011).	Disclosed in part	26
A-2011-00983	All documents relating to the assessment of the safety and efficacy of the following enzyme: Fungal Proteases.	Disclosed in part	38
A-2011-00984	All documents to the assessment of the safety and efficacy of the following enzyme: alpha-Galactosidase.	All disclosed	38
A-2011-00985	All documents relating to the assessment of the safety and efficacy of the following enzyme: Fruit Bromelain.	Disclosed in part	65
A-2011-00986	All documents relating to the assessment of the safety and efficacy of the following enzyme: Stem Bromelain.	Disclosed in part	61
A-2011-00987	All documents relating to the assessment of the safety and efficacy of the following enzyme: Papain.	Disclosed in part	108
A-2011-01135	DIGENE hc2 Human Papillomavirus (HPV) Test. Information related to the in vitro diagnostic device DIGENE DML-2000 HPV HYBRID CAPTURE II by Qiagen (Medical Device License No. 2767).	All disclosed	15
A-2011-01208	All of the opinion research - public and other opinion polling, focus group analysis, etc., which Health Canada has carried out with regard to the issue of climate change. (Jan 1, 2008 to Dec 14, 2011).	Disclosed in part	1,639
A-2011-01244	All documents prepared by, for Health Canada in relation to the consultation or other services provided to Health Canada by 1649244 Ontario Inc. (Jul 1, 2011 to Dec 15, 2011).	No records exist	0
A-2011-01255	Briefing notes and e-mails created to brief Health Minister Leona Aglukkaq and/or Parliamentary Secretary Colin Carrie and/or the deputy minister of health on the drug shortage in Canada. (Jul 1, 2011 to Dec 22, 2011).	Disclosed in part	86
A-2011-01266	All question period cards prepared for the Minister. (Oct 22, 2011 to Dec 15, 2011).	Disclosed in part	582
A-2011-01384	Various information relating to the Gates Foundation.	No records exist	0
A-2011-01401	Product Monograph for the product PENTOTHAL, DINs 000695017, 0 00038393, 0 00372536, 000038407 and 0 00038415 by Hospira healthcare corporation.	All disclosed	23
A-2011-01411	All correspondence between Health Canada and any Government of Canada or Government of Quebec, in relation to funding, lines of credit, loans for Jeffrey Mine Inc. (Jul 1, 2010 to Mar 2, 2012).	Disclosed in part	106
A-2011-01441	Information regarding the product Biosilica Plus - Silica Gel, NPN 80017881.	Disclosed in part	27
A-2011-01563	AERs for the product Avelox. Report numbers: 000377884, 000378444, 000378637, 000379848, 000379894 and 000380186.	Disclosed in part	13
A-2011-01566	AERs for the product Levitra. Report numbers: 000378407 and 000378108.	Disclosed in part	4
A-2011-01570	AERs for the product Yasmin. Report numbers: 000378245, 000378484, 000379351 and 000379964.	Disclosed in part	7
A-2011-01597	Radon reports for the Royal Canadian Mounted Police detachment building in Elkford, British Columbia.	Disclosed in part	179
A-2011-01620	How many applications made under the Marihuana Medical Access Regulations were deemed incomplete or otherwise rejected. For the following fiscal years: 2008/09, 2009/10 and 2010/11.	No records exist	0
A-2011-01639	All communication involving the Minister's Office on the issue of Chronic cerebrospinal venous insufficiency (CCSVI). (Nov 1, 2011 to Dec 15, 2011).	Disclosed in part	38
A-2011-01640	All communications involving the Minister Office on the issue of Chronic cerebrospinal venous insufficiency (CCSVI). (Jan 1, 2012 to Feb 29, 2012).	Disclosed in part	191
A-2011-01726	A listing of the Access to Information requests, from the media, submitted to Health Canada. (Jul 1, 2006 to Feb 20, 2012).	Disclosed in part	242
A-2011-01743	A list of all reports prepared by or for Health Canada's Forensic Audit Investigations unit related to the Non-Insured Health Benefits Program. (Jan 1, 2009 to Mar 27, 2012).	No records exist	0
A-2011-01744	A list of all reports prepared by or for Health Canada's Audit and Accountability Bureau related to the Non-Insured Health Benefits Program on suspected fraud or allegations of fraud. (Jan 1, 2009 to Mar 27, 2012).	All disclosed	1
A-2011-01747	A list of written notifications submitted to the Minister from a person with an expired authorization to possess or licence to produce outlining the destruction of their marihuana under the following section of the Marihuana Medical Access Regulations: 65. 1), 2) and 3).	No records exist	0
A-2011-01756	Applicant data regarding the agency's medicinal marijuana program from the last years (2011).	No records exist	0
A-2011-01757	List of studies that were included in the review conducted by the Expert panel on fluoride convened by Health Canada in 2007.	No records exist	0
A-2011-01763	Log of all incidents and/or complications occurring in possible relation to the use of contact lens blanks subject to the Consumer Product Safety Act. (Mar 31, 2002 to Mar 30, 2012).	Disclosed in part	53
A-2012-00003	Information regarding; the Gazette Vol. 141 No 26 - June 30 2007, authority to prescribe controlled substances, member lists of various controlled substances authorizing committees.	Disclosed in part	7
A-2012-00004	AERs for the product Aleve. Report numbers: 000387097 and 000398157.	Disclosed in part	3
A-2012-00006	All information relating to the Sainte-Anne-de-Bellevue Hospital transfer - health system monitoring. (Jan 1, 2009 to Apr 24, 2012).	All disclosed	19
A-2012-00009	All call-ups processed by this institution in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of March 2012.	Disclosed in part	52
A-2012-00012	All documents regarding Nebenaigoching Heritage Inc. (Jun 1, 2011 to Apr 5, 2012).	No records exist	0
A-2012-00013	All documents held by your department relating to the purchase of any type of alcoholic beverages by your department, including in relation to receptions, cocktail parties, restaurant meals for government employees or other persons from Health Canada or business travel by government employees; in short, expenditures per year on alcohol. (Apr 6, 2005 to Apr 5, 2010).	No records exist	0
A-2012-00014	AER for the product Ultiva. Report number: 000374589.	Disclosed in part	4
A-2012-00025	Documentation which indicates all appointments term and casual employees by this institution in the National Capital Region under the term of the Public Service Employment Act during March 2012.	All disclosed	1
A-2012-00031	A list of inspections (including the province where the inspections were executed) conducted under the Marihuana Medical Access Regulations.	No records exist	0
A-2012-00032	Inspection reports and/or documents generated from inspections conducted under the Marihuana Medical Access Regulations. (Apr 13, 2008 to Apr 12, 2012).	No records exist	0
A-2012-00034	List of public complaints about authorized marihuana users to inspectors as well as any reports of this to the Minister. (Apr 13, 2008 to Apr 12, 2012).	No records exist	0
A-2012-00035	AER for the product BIAXIN. Report number: 000367955.	Disclosed in part	7
A-2012-00037	A list of police requests, and the nature of the requests, to the 24-hours hotline concerning a person who is a holder of an authorization to possess or licence to produce under the Marihuana Medical Access Regulations which Health Canada has been involved in the last three years. (Apr 13, 2008 to Apr 12, 2012).	No records exist	0
A-2012-00041	All documents with relating to the Letter to the Editor produced by Health Canada regarding the article 'A Shortage of Foresight'.	Disclosed in part	175
A-2012-00045	AERs for the product Avelox. Report numbers: 000383265, 000384627, 000384655, 000384752, 000385183, 000385328, 000387043, 000387186, 000387790 and 000389745.	Disclosed in part	15
A-2012-00047	AER for the product Avelox IV. Report number: 000385674.	Disclosed in part	1
A-2012-00050	AERs for the product Magnevist. Report numbers: 000385825 and 000386387.	Disclosed in part	3
A-2012-00051	AERs for the product Mirena. Report numbers: 000385306 and 000385538.	Disclosed in part	3
A-2012-00052	AER for the product Nexavar. Report number: 000386139.	Disclosed in part	2
A-2012-00053	AER for the product Yasmin. Report number: 000386383.	Disclosed in part	1
A-2012-00055	All documents related to plans, by any of the provincial Ministries of Health to make significant changes, to the manner in which insured health are provided.	No records exist	0
A-2012-00056	AERs for the product Alvesco. Report numbers: 000384369 and 000385571.	Disclosed in part	2
A-2012-00063	AERs for the product WInRho. Report numbers: 000378615 and 000377089.	Disclosed in part	6
A-2012-00064	AER for the product Adcira. Report number: 000382312.	Disclosed in part	2
A-2012-00065	AER for the product Alimta. Report number: 000396581.	Disclosed in part	1
A-2012-00068	AER for the product Effient. Report number: 000396180.	Disclosed in part	1
A-2012-00071	AER for the product Forteo. Report number: 000387887.	Disclosed in part	1
A-2012-00072	AER for the product Gemzar. Report number: 000396186.	Disclosed in part	1
A-2012-00074	AERs for the product Prozac. Report numbers: 000385025 and 000385353.	Disclosed in part	2
A-2012-00089	Regarding the health study on industrial wind turbines, request the list of members, their role, credentials and expertise on the subject of industrial wind turbines; the method of selection of the members, and full disclosure regarding the affiliation of each member including that of consultants and advisors.	Disclosed in part	8
A-2012-00094	All documents that describe, explore, examine, or pertain in any way to how the changes brought in Sections 44-46 of Bill C-10 affect past scheduling decisions made by the Office of Controlled Substances (OCS), as well as their impact on current and future scheduling decisions.	No records exist	0
A-2012-00095	Lists of compounds, substances, chemicals, plants or animals that have been reviewed and deemed controlled and have been reviewed by the Office of Controlled Substances. (Everything up until Apr 24, 2012).	All disclosed	300
A-2012-00098	Detailed receipts and reimbursement documents for the following trips as found in the proactive disclosure online information: by Michel Roy to Vancouver during the period October 12-14 2011.	Disclosed in part	14
A-2012-00099	A listing of the vehicle fleet owned or leased, and available for the transportation of the minister or deputy minister or senior executives for crown corporations.	All disclosed	1
A-2012-00101	Complete copy of the following reports: Health Canada's National Radon Program: Radon Testing in Federal Buildings, Health Canada, November 2010 Cross-Canada Survey of Radon Concentrations in Homes: Year 1 Interim Report, Health Canada, December 2010 Cross-Canada Survey of Radom Concentrations in Homes: Year 1 Survey Report, Prairie Research Associates, July 5, 2010 Cross-Canada Survey of Radom Concentrations in Homes: Year 2 Report, Prairie Research Associates, July 29, 2011 Cross-Canada Survey of Radom Concentrations in Homes: Survey Report for Year 1 and Year 2, Prairie Research Associates, July 29, 2011	All disclosed	96
A-2012-00102	Documents showing the number of cell phones/smart phones issued to national capital region based employees as well as the cost of cell phone/smart phone use for the 2011/2012 fiscal year.	All disclosed	1
A-2012-00110	All documents relating to total expenditures per year on taxi travel (2005 to 2012).	All disclosed	1
A-2012-00113	Information and data on air quality samples taken on all floors in the Jeanne Mance Building at 200 Eglantine Drive. (Jan 1, 2012 to Mar 31, 2012).	No records exist	0
A-2012-00128	List of all funding provided to anti-smoking and anti-tobacco groups by Health Canada. (Apr 1, 2010 to May 1, 2012).	All disclosed	1
A-2012-00129	All expense claims, including attached receipts, submitted by Cathy Sabiston, Director General, Controlled Substances and Tobacco. (Jan 1, 2011 to May 1, 2012).	Disclosed in part	155
A-2012-00133	All briefing notes prepared for the Minister of Health or her staff on the subject of tobacco/cigarette labelling. (Jan 1, 2012 to May 1, 2012).	No records exist	0
A-2012-00134	All expense claims, including attached receipts, submitted by Denis Choinière. (Jan 1, 2011 to May 1, 2012).	Disclosed in part	218
A-2012-00138	Information regarding an agreement or terms of the Canada Health and Social Transfer (CHST) for the social assistance program within the meaning at section 18 and with specific reference to the prohibition in part V of the Federal-Provincial Fiscal Arrangements Act against a requirement of residency (or condition of residency) for receipt of social assistance to a person in need for benefits in any form as between the government of Québec. (Aug 1, 2003 to May 3, 2012).	No records exist	0
A-2012-00215	All communications, proposals, bids and contracts related to Lockheed Martin Corporation, or any other Lockheed Martin business entity or representative/lobbyist. (Sep 1, 2001 to May 17, 2012).	No records exist	0